Benjamin D Bray1, James Campbell, Geoffrey C Cloud, Alex Hoffman, Pippa J Tyrrell, Charles D A Wolfe, Anthony G Rudd. 1. From the Division of Health and Social Care Research, King's College London, London, United Kingdom (B.D.B., C.D.A.W., A.G.R.); Royal College of Physicians, London, United Kingdom (J.C., A.H.); St George's Hospital, London, United Kingdom (C.C.G.); University of Manchester, MAHSC, Salford Royal NHS Foundation Trust, Salford, United Kingdom (P.J.T.); and National Institute for Health Research Comprehensive Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom (C.D.A.W., A.G.R.).
Abstract
BACKGROUND AND PURPOSE: There is evidence that high-volume hospitals may produce better patient outcomes. We aimed to identify whether there were any associations between hospital thrombolysis volume and speed of thrombolysis (tissue-type plasminogen activator [tPA]) administration in patients with ischemic stroke. METHODS: Data were drawn from 2 national clinical audits in England: the Stroke Improvement National Audit Program and the 2012 Sentinel Stroke Audit. Hospitals were categorized into 3 groups based on the annualized volume of thrombolysis: 0 to 24, 25 to 49, and ≥50 cases per annum. Arrival-brain scan, onset-tPA, and arrival-tPA times were compared across groups and stratified by onset-arrival time. Multilevel logistic models were used to estimate the odds of receiving tPA within 60 minutes of arrival. RESULTS: Of the 42 024 patients with acute ischemic stroke admitted to 80 hospitals, 4347 received tPA (10.3%). Patients admitted to hospitals with an annual thrombolysis volume of ≥50 cases per annum had median arrival-tPA times that were 28 and 22 minutes shorter than patients admitted to hospitals with volumes of 0 to 24 and 25 to 49, respectively. Onset-tPA times were shorter by 24 to 32 minutes across strata of onset-arrival times. In multivariable analysis, patients admitted to hospitals with a volume of ≥50 cases per annum had 4.33 (2.21-8.50; P<0.0001) the odds of receiving tPA within 60 minutes of arrival. No differences in safety outcomes were observed, with similar 30-day mortality and complication rates across the groups. CONCLUSIONS: Hospitals with higher volumes of thrombolysis activity achieve statistically and clinically significant shorter delays in administering tPA to patients after arrival in hospital.
BACKGROUND AND PURPOSE: There is evidence that high-volume hospitals may produce better patient outcomes. We aimed to identify whether there were any associations between hospital thrombolysis volume and speed of thrombolysis (tissue-type plasminogen activator [tPA]) administration in patients with ischemic stroke. METHODS: Data were drawn from 2 national clinical audits in England: the Stroke Improvement National Audit Program and the 2012 Sentinel Stroke Audit. Hospitals were categorized into 3 groups based on the annualized volume of thrombolysis: 0 to 24, 25 to 49, and ≥50 cases per annum. Arrival-brain scan, onset-tPA, and arrival-tPA times were compared across groups and stratified by onset-arrival time. Multilevel logistic models were used to estimate the odds of receiving tPA within 60 minutes of arrival. RESULTS: Of the 42 024 patients with acute ischemic stroke admitted to 80 hospitals, 4347 received tPA (10.3%). Patients admitted to hospitals with an annual thrombolysis volume of ≥50 cases per annum had median arrival-tPA times that were 28 and 22 minutes shorter than patients admitted to hospitals with volumes of 0 to 24 and 25 to 49, respectively. Onset-tPA times were shorter by 24 to 32 minutes across strata of onset-arrival times. In multivariable analysis, patients admitted to hospitals with a volume of ≥50 cases per annum had 4.33 (2.21-8.50; P<0.0001) the odds of receiving tPA within 60 minutes of arrival. No differences in safety outcomes were observed, with similar 30-day mortality and complication rates across the groups. CONCLUSIONS: Hospitals with higher volumes of thrombolysis activity achieve statistically and clinically significant shorter delays in administering tPA to patients after arrival in hospital.
Authors: Jens Fiehler; Christophe Cognard; Mauro Gallitelli; Olav Jansen; Adam Kobayashi; Heinrich P Mattle; Keith W Muir; Mikael Mazighi; Karl Schaller; Peter D Schellinger Journal: Eur Stroke J Date: 2016-07-26
Authors: Michael Allen; Kerry Pearn; Martin James; Gary A Ford; Phil White; Anthony G Rudd; Peter McMeekin; Ken Stein Journal: Eur Stroke J Date: 2018-07-19
Authors: Laura C C van Meenen; Sanne J den Hartog; Adrien E Groot; Bart J Emmer; Martin D Smeekes; Arjen Siegers; Geert Jan Kommer; Charles B L M Majoie; Yvo B W E M Roos; Adriaan C G M van Es; Diederik W Dippel; H Bart van der Worp; Hester F Lingsma; Bob Roozenbeek; Jonathan M Coutinho Journal: Eur J Neurol Date: 2021-09-23 Impact factor: 6.288
Authors: Christine L Paul; Annika Ryan; Shiho Rose; John R Attia; Erin Kerr; Claudia Koller; Christopher R Levi Journal: Implement Sci Date: 2016-04-08 Impact factor: 7.327
Authors: Adrien E Groot; Ivo N van Schaik; Marieke C Visser; Paul J Nederkoorn; Martien Limburg; Majid Aramideh; Frank de Beer; Caspar P Zwetsloot; Patricia Halkes; Jelle de Kruijk; Nyika D Kruyt; Willem van der Meulen; Fianne Spaander; Taco van der Ree; Vincent I H Kwa; Renske M Van den Berg-Vos; Yvo B Roos; Jonathan M Coutinho Journal: J Neurol Date: 2016-03-05 Impact factor: 4.849